Correlation Between Salarius Pharmaceuticals and FWBI Old
Can any of the company-specific risk be diversified away by investing in both Salarius Pharmaceuticals and FWBI Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salarius Pharmaceuticals and FWBI Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salarius Pharmaceuticals and FWBI Old, you can compare the effects of market volatilities on Salarius Pharmaceuticals and FWBI Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salarius Pharmaceuticals with a short position of FWBI Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salarius Pharmaceuticals and FWBI Old.
Diversification Opportunities for Salarius Pharmaceuticals and FWBI Old
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Salarius and FWBI is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and FWBI Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FWBI Old and Salarius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salarius Pharmaceuticals are associated (or correlated) with FWBI Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FWBI Old has no effect on the direction of Salarius Pharmaceuticals i.e., Salarius Pharmaceuticals and FWBI Old go up and down completely randomly.
Pair Corralation between Salarius Pharmaceuticals and FWBI Old
If you would invest 155.00 in Salarius Pharmaceuticals on December 20, 2024 and sell it today you would lose (69.00) from holding Salarius Pharmaceuticals or give up 44.52% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Salarius Pharmaceuticals vs. FWBI Old
Performance |
Timeline |
Salarius Pharmaceuticals |
FWBI Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Salarius Pharmaceuticals and FWBI Old Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Salarius Pharmaceuticals and FWBI Old
The main advantage of trading using opposite Salarius Pharmaceuticals and FWBI Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salarius Pharmaceuticals position performs unexpectedly, FWBI Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FWBI Old will offset losses from the drop in FWBI Old's long position.Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. SAB Biotherapeutics | Salarius Pharmaceuticals vs. GeoVax Labs |
FWBI Old vs. Quoin Pharmaceuticals Ltd | FWBI Old vs. Revelation Biosciences | FWBI Old vs. Dermata Therapeutics | FWBI Old vs. LMF Acquisition Opportunities |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |